Menu
Last year’s edition of Science for health addressed key topics around the theme of “Biology meets technology”, such as:
Innovations of strategic importance will be featured, highlighting how technology has played a role in their discovery and development. New generations of therapeutics and vaccines with great promise for clinical development will be staged.
Turning innovative leads into medicines: we will discuss what the factory of the future will look like. How can we effectively implement novel tools such as data analytics, robotics and automation in development of your innovation?
There are certain opportunities and challenges Belgium faces, in its way to become a leading region. Which regulatory challenges can we envision and what does the ideal investment climate look like? How can we optimally build talent?
You will also learn which technology needs require solutions. How can we use diagnostic tools to develop biomarkers accompanying innovative treatments and support precision medicine? How are data and AI/ML used to develop better drugs more efficiently?
Science for health 2021 facilitated cross-ecosystem networking between academics, industry leaders, and policymakers. By forming connections across the ecosystem, the event has helped to enable collaborations for Data Science in Belgium and beyond.
The event provided actionable insights to attendees, while acknowledging different
stakeholder needs. Through good media coverage and by fostering cooperation, this edition is accelerating progress in the vital topic of Data Science in health.
Local and international speakers presented engaging talks, featuring examples of big data successfully being used to improve healthcare, as well as earnest discussions about the steps needed to enable real-world data research in the future.
On 11 September 2019, 15 (inter)national top speakers joined us in Brussels and presented on all aspects of cell therapy, from fundamental research breakthroughs to the clinical and regulatory challenges of bringing these innovations to the patient. Dr Carl June, the father of CAR T immunotherapy, opened the conference.
19 cell therapy companies and research institutes presented their work at a (free) booth, resulting in high-quality interaction with the ecosystem.
Reaching a balanced audience of 327 participants, the event was sold out over 1 month in advance
Cookies